Site Analytics
Page Visit Statistics
Page visits
9,542
group + drug pages, all time
Group pages
4,277
54 groups visited
Drug pages
5,265
150 drugs visited
Most visited
684 visits · top drug: Osimertinib
By drug category
share of all page visits
Targeted Therapy 4,902
(51.4%)
Monoclonal Antibodies (mAbs) 3,326
(34.9%)
Immunotherapy 600
(6.3%)
Antibody-Drug Conjugates (ADCs) 569
(6.0%)
Gene Therapy 145
(1.5%)
Drug groups and their drugs
54 groups · click a group to see its drugs
group page
its drug pages
Anti-PD-(L)1 mAb
Monoclonal Antibodies (mAbs)
1,479
684 group · 795 drugs
Atezolizumab
95
Durvalumab
68
Nivolumab
64
Camrelizumab
55
Tislelizumab
49
Avelumab
48
Sintilimab
44
Retifanlimab
42
Penpulimab
41
Cosibelimab
38
Cemiplimab
37
Toripalimab
37
Dostarlimab
35
Serplulimab
31
Sugemalimab
31
Multi-target TKI
Targeted Therapy
1,018
371 group · 647 drugs
Cabozantinib
72
Crizotinib
56
Lenvatinib
54
Axitinib
50
Lapatinib
42
Entrectinib
40
Regorafenib
40
Sunitinib
39
Pazopanib
38
Nintedanib
33
Sorafenib
33
Vandetanib
31
Nilotinib
29
Avapritinib
27
Ripretinib
26
EGFR targeting TKI
Targeted Therapy
787
326 group · 461 drugs
Osimertinib
110
Afatinib
75
Icotinib
53
Gefitinib
45
Erlotinib
43
Lazertinib
42
Mobocertinib
33
Dacomitinib
29
ADC
Antibody-Drug Conjugates (ADCs)
569
235 group · 334 drugs
VEGF mAb
Monoclonal Antibodies (mAbs)
437
303 group · 134 drugs
Bevacizumab
89
Ramucirumab
45
PARP inhibitor
Targeted Therapy
377
190 group · 187 drugs
anti-HER2 mAb
Monoclonal Antibodies (mAbs)
287
69 group · 218 drugs
ALK targeting TKI
Targeted Therapy
253
74 group · 179 drugs
Anti-EGFR mAb
Monoclonal Antibodies (mAbs)
250
127 group · 123 drugs
BRAF inhibitor
Targeted Therapy
242
111 group · 131 drugs
CDK4/6 inhibitor
Targeted Therapy
238
128 group · 110 drugs
mTOR
Targeted Therapy
172
49 group · 123 drugs
BiTE
Immunotherapy
161
77 group · 84 drugs
Therapeutic Vaccines
Immunotherapy
156
42 group · 114 drugs
Gene Therapy
Gene Therapy
145
103 group · 42 drugs
HER(2) targeting TKI
Targeted Therapy
140
33 group · 107 drugs
VEGFR targeting TKI
Targeted Therapy
140
38 group · 102 drugs
Anti-CTLA-4 mAb
Monoclonal Antibodies (mAbs)
136
65 group · 71 drugs
Ipilimumab
38
Tremelimumab
33
Cytokine Modulators
Immunotherapy
132
45 group · 87 drugs
MEK inhibitor
Targeted Therapy
132
56 group · 76 drugs
FGFR targeting TKI
Targeted Therapy
120
30 group · 90 drugs
KRAS Inhibitors
Targeted Therapy
101
45 group · 56 drugs
Anti-RANKL mAb
Monoclonal Antibodies (mAbs)
99
64 group · 35 drugs
Denosumab
35
anti-GD2 mAb
Monoclonal Antibodies (mAbs)
87
28 group · 59 drugs
Naxitamab
33
Dinutuximab
26
PI3K inhibitor
Targeted Therapy
86
40 group · 46 drugs
Alpelisib
23
Inavolisib
23
VEGF-trap
Targeted Therapy
81
50 group · 31 drugs
Aflibercept
31
CAR-T or Cell Therapy
Immunotherapy
76
39 group · 37 drugs
Oncolytic virus
Immunotherapy
75
48 group · 27 drugs
Anti-LAG-3 mAb
Monoclonal Antibodies (mAbs)
73
42 group · 31 drugs
Relatlimab
31
RAF–MEK clamp
Targeted Therapy
73
43 group · 30 drugs
Avutometinib
30
anti-EGFR/MET mAb
Monoclonal Antibodies (mAbs)
72
41 group · 31 drugs
Amivantamab
31
Anti-PDGFRα mAb
Monoclonal Antibodies (mAbs)
70
32 group · 38 drugs
Olaratumab
38
Hedgehog Pathway Inhibitors
Targeted Therapy
69
29 group · 40 drugs
Sonidegib
23
Vismodegib
17
RET targeting TKI
Targeted Therapy
69
31 group · 38 drugs
Pralsetinib
16
IDH inhibitor
Targeted Therapy
67
23 group · 44 drugs
Ivosidenib
25
Vorasidenib
19
anti-CCR4 mAb
Monoclonal Antibodies (mAbs)
67
34 group · 33 drugs
TRK targeting TKI
Targeted Therapy
64
28 group · 36 drugs
AKT inhibitor
Targeted Therapy
63
43 group · 20 drugs
Capivasertib
20
MET targeting TKI
Targeted Therapy
63
27 group · 36 drugs
Capmatinib
18
Tepotinib
18
ClpP protease activator
Targeted Therapy
62
23 group · 39 drugs
Dordaviprone
39
ROS1 targeting TKI
Targeted Therapy
61
26 group · 35 drugs
Somatostatin analog
Targeted Therapy
61
32 group · 29 drugs
Lanreotide
29
HIF-2α inhibitor
Targeted Therapy
60
31 group · 29 drugs
Belzutifan
29
anti-CSF1R mAb
Monoclonal Antibodies (mAbs)
59
32 group · 27 drugs
Gamma-secretase inhibitor
Targeted Therapy
58
28 group · 30 drugs
Nirogacestat
30
anti-claudin 18.2 mAb
Monoclonal Antibodies (mAbs)
58
19 group · 39 drugs
Zolbetuximab
39
JAK inhibitor
Targeted Therapy
54
35 group · 19 drugs
Ruxolitinib
19
anti-GITR mAb
Monoclonal Antibodies (mAbs)
54
39 group · 15 drugs
BMS-986156
15
Anti-idiotype vaccine mAb
Monoclonal Antibodies (mAbs)
51
31 group · 20 drugs
Racotumomab
20
CSF1R targeting TKI
Targeted Therapy
49
32 group · 17 drugs
Vimseltinib
17
FAK/Pyk2 inhibitor
Targeted Therapy
48
26 group · 22 drugs
Defactinib
22
Aurora A kinase inhibitor
Targeted Therapy
47
26 group · 21 drugs
alisertib
21
CD137 agonist mAb
Monoclonal Antibodies (mAbs)
47
26 group · 21 drugs
Urelumab
21
EZH2 inhibitor
Targeted Therapy
47
28 group · 19 drugs
Tazemetostat
19
No group or drug matches your search.